Bitte benutzen Sie diese Kennung, um auf die Ressource zu verweisen:
https://doi.org/10.21256/zhaw-23574| Publikationstyp: | Konferenz: Poster |
| Art der Begutachtung: | Peer review (Abstract) |
| Titel: | Beliefs about medicines in patients with multiple myeloma in Switzerland |
| Autor/-in: | Altwicker-Hámori, Szilvia Juvalta, Sibylle Bargetzi, Mario Renner, Christoph Taverna, Christina Dratva, Julia |
| et. al: | No |
| DOI: | 10.4414/smw.2021.w30107 10.21256/zhaw-23574 |
| Erschienen in: | Swiss Medical Weekly |
| Band(Heft): | 151 |
| Heft: | Supplementum 255 |
| Seite(n): | 28 |
| Seiten bis: | 29 |
| Angaben zur Konferenz: | 4th Swiss Oncology & Hematology Congress (SOHC), Zurich, 18-20 November 2021 |
| Erscheinungsdatum: | 18-Nov-2021 |
| Verlag / Hrsg. Institution: | EMH Swiss Medical Publishers |
| ISSN: | 2504-1622 |
| Sprache: | Englisch |
| Fachgebiet (DDC): | 616: Innere Medizin und Krankheiten |
| Zusammenfassung: | Background: Medication beliefs have been found to be associated with medication adherence among various cancer patients. Despite its importance, medication beliefs have not been investigated in patients with multiple myeloma (MM). A study on quality of life in MM patients provided the opportunity to fill this gap. Methods: Patients were recruited consecutively from three Swiss oncology/hematology centres. Inclusion criteria included confirmed histological MM diagnosis, age ≥18 years and informed consent. Exclusion criteria were participation in another clinical study, inability to communicate in German and more than one cancer diagnosis. Participants completed a survey including the Beliefs about Medicines Questionnaire (BMQ) and a sociodemographic questionnaire. Clinical data was extracted from medical records. The complete case dataset (N = 41) was analysed using descriptive statistical methods. Results: Most participants were men (59%), married/partnered (80%), born in Switzerland (80%), economically inactive (85%) and completed at most upper secondary education (72%). Mean age at diagnosis was 61 years (range: 35-81 years). 48% of the participants were in a stable/plateau phase, 37% in a relapsed/progressive phase and 15% newly diagnosed; 96% had good ECOG performance status. Table 1 presents the results of the BMQ. The vast majority of the sample believed in the necessity of their medication for maintaining their health; however, 70% reported concerns about their long-term effects. The specific-necessity subscale and general-harm subscale showed the highest and lowest mean, respectively. Conclusions: The results indicate higher necessity beliefs than concerns towards MM medication. Specific items point to topics to be raised by treating physicians. |
| URI: | https://digitalcollection.zhaw.ch/handle/11475/23574 |
| Volltext Version: | Publizierte Version |
| Lizenz (gemäss Verlagsvertrag): | CC BY-NC-SA 4.0: Namensnennung - Nicht-kommerziell - Weitergabe unter gleichen Bedingungen 4.0 International |
| Departement: | Gesundheit School of Management and Law |
| Organisationseinheit: | Institut für Public Health (IPH) Winterthurer Institut für Gesundheitsökonomie (WIG) |
| Publiziert im Rahmen des ZHAW-Projekts: | Lebensqualität bei Myelom Patientinnen und Patienten in drei Schweizer Kliniken |
| Enthalten in den Sammlungen: | Publikationen Gesundheit Publikationen School of Management and Law |
Dateien zu dieser Ressource:
| Datei | Beschreibung | Größe | Format | |
|---|---|---|---|---|
| 2021_AltwickerHamori-etal_Beliefs-about-medicine-myeloma-patients-CH.pdf | 155.8 kB | Adobe PDF |  Öffnen/Anzeigen |
Zur Langanzeige
Altwicker-Hámori, S., Juvalta, S., Bargetzi, M., Renner, C., Taverna, C., & Dratva, J. (2021). Beliefs about medicines in patients with multiple myeloma in Switzerland [Conference poster]. Swiss Medical Weekly, 151(Supplementum 255), 28–29. https://doi.org/10.4414/smw.2021.w30107
Altwicker-Hámori, S. et al. (2021) ‘Beliefs about medicines in patients with multiple myeloma in Switzerland’, in Swiss Medical Weekly. EMH Swiss Medical Publishers, pp. 28–29. Available at: https://doi.org/10.4414/smw.2021.w30107.
S. Altwicker-Hámori, S. Juvalta, M. Bargetzi, C. Renner, C. Taverna, and J. Dratva, “Beliefs about medicines in patients with multiple myeloma in Switzerland,” in Swiss Medical Weekly, Nov. 2021, vol. 151, no. Supplementum 255, pp. 28–29. doi: 10.4414/smw.2021.w30107.
ALTWICKER-HÁMORI, Szilvia, Sibylle JUVALTA, Mario BARGETZI, Christoph RENNER, Christina TAVERNA und Julia DRATVA, 2021. Beliefs about medicines in patients with multiple myeloma in Switzerland. In: Swiss Medical Weekly. Conference poster. EMH Swiss Medical Publishers. 18 November 2021. S. 28–29
Altwicker-Hámori, Szilvia, Sibylle Juvalta, Mario Bargetzi, Christoph Renner, Christina Taverna, and Julia Dratva. 2021. “Beliefs About Medicines in Patients with Multiple Myeloma in Switzerland.” Conference poster. In Swiss Medical Weekly, 151:28–29. EMH Swiss Medical Publishers. https://doi.org/10.4414/smw.2021.w30107.
Altwicker-Hámori, Szilvia, et al. “Beliefs About Medicines in Patients with Multiple Myeloma in Switzerland.” Swiss Medical Weekly, vol. 151, no. Supplementum 255, EMH Swiss Medical Publishers, 2021, pp. 28–29, https://doi.org/10.4414/smw.2021.w30107.
Alle Ressourcen in diesem Repository sind urheberrechtlich geschützt, soweit nicht anderweitig angezeigt.